Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 826180, 8 pages
http://dx.doi.org/10.1155/2015/826180
Research Article

Serum Soluble Adhesion Molecules and Markers of Systemic Inflammation in Elderly Diabetic Patients with Mild Cognitive Impairment and Depressive Symptoms

1Department of Internal Medicine and Diabetology, Medical University of Lodz, 251 Pomorska Street, 92-213 Lodz, Poland
2Department of General and Oncological Pneumology, Medical University of Lodz, 22 Kopcinskiego Street, 90-153 Lodz, Poland

Received 21 January 2015; Accepted 12 May 2015

Academic Editor: Cristiano Capurso

Copyright © 2015 Malgorzata Gorska-Ciebiada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Petersen, “Mild cognitive impairment,” The New England Journal of Medicine, vol. 364, no. 23, pp. 2227–2234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Petersen, R. O. Roberts, D. S. Knopman et al., “Mild cognitive impairment: ten years later,” Archives of Neurology, vol. 66, no. 12, pp. 1447–1455, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. l. Plassman, K. M. Langa, G. G. Fisher et al., “Prevalence of cognitive impairment without dementia in the United States,” Annals of Internal Medicine, vol. 148, pp. 427–434, 2008. View at Google Scholar
  4. M. W. J. Strachan, R. M. Reynolds, R. E. Marioni, and J. F. Price, “Cognitive function, dementia and type 2 diabetes mellitus in the elderly,” Nature Reviews Endocrinology, vol. 7, no. 2, pp. 108–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Hermida, W. M. McDonald, K. Steenland, and A. Levey, “The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?” Expert Review of Neurotherapeutics, vol. 12, no. 11, pp. 1339–1350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Yaffe, “Metabolic syndrome and cognitive disorders: is the sum greater than its parts?” Alzheimer Disease and Associated Disorders, vol. 21, no. 2, pp. 167–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. O. Roberts, Y. E. Geda, D. S. Knopman et al., “Metabolic syndrome, inflammation, and non-amnestic mild cognitive impairment in older persons: a population-based study,” Alzheimer Disease and Associated Disorders, vol. 24, no. 1, pp. 11–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. P. Devanand, M. Sano, M. X. Tang et al., “Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community,” Archives of General Psychiatry, vol. 53, no. 2, pp. 175–182, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Panza, V. Frisardi, C. Capurso et al., “Late-life depression, mild cognitive impairment, and dementia: possible continuum?” The American Journal of Geriatric Psychiatry, vol. 18, no. 2, pp. 98–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Pizzi, L. Manzoli, S. Mancini, and G. M. Costa, “Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function,” European Heart Journal, vol. 29, no. 9, pp. 1110–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gorska-Ciebiada, M. Saryusz-Wolska, and J. Loba, “Mild cognitive impairment and depressive symptoms in elderly patients with diabetes- prevalence, risk factors and co-morbidity,” Journal of Diabetes Research, vol. 2014, Article ID 179648, 7 pages, 2014. View at Publisher · View at Google Scholar
  12. Z. S. Nasreddine, N. A. Phillips, V. Bédirian et al., “The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment,” Journal of the American Geriatrics Society, vol. 53, no. 4, pp. 695–699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Yesavage, T. L. Brink, T. L. Rose et al., “Development and validation of a geriatric depression screening scale: a preliminary report,” Journal of Psychiatric Research, vol. 17, no. 1, pp. 37–49, 1982. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Katz, T. D. Downs, H. R. Cash, and R. C. Grotz, “Progress in development of the index of ADL,” The Gerontologist, vol. 10, no. 1, part 1, pp. 20–30, 1970. View at Publisher · View at Google Scholar · View at Scopus
  15. M. P. Lawton and E. M. Brody, “Assessment of older people: self-maintaining and instrumental activities of daily living,” Gerontologist, vol. 9, no. 3, pp. 179–186, 1969. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Alagiakrishnan, N. Zhao, L. Mereu, P. Senior, and A. Senthilselvan, “Montreal cognitive assessment is superior to standardized mini-mental status exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus,” BioMed Research International, vol. 2013, Article ID 186106, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Petersen, “Mild cognitive impairment as a diagnostic entity,” Journal of Internal Medicine, vol. 256, no. 3, pp. 183–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Portet, P. J. Ousset, P. J. Visser et al., “Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 6, pp. 714–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Elhadd, G. Kennedy, R. Robb, M. McLaren, R. T. Jung, and J. J. F. Belch, “Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease,” International Angiology, vol. 23, no. 2, pp. 128–133, 2004. View at Google Scholar · View at Scopus
  20. M. S. Boulbou, G. N. Koukoulis, K. G. Vasiou, E. A. Petinaki, K. I. Gourgoulianis, and I. B. Fezoulidis, “Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease,” International Angiology, vol. 23, no. 1, pp. 18–24, 2004. View at Google Scholar · View at Scopus
  21. V. Novak, P. Zhao, B. Manor et al., “Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes,” Diabetes Care, vol. 34, no. 11, pp. 2438–2441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Umemura, T. Kawamura, H. Umegaki et al., “Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 11, pp. 1186–1194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Ding, M. W. J. Strachan, R. M. Reynolds et al., “Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study,” Diabetes, vol. 59, no. 11, pp. 2883–2889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Raison and A. H. Miller, “Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment,” Modern Trends in Pharmacopsychiatry, vol. 28, pp. 33–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. B. E. Leonard, “Inflammation, depression and dementia: are they connected?” Neurochemical Research, vol. 32, no. 10, pp. 1749–1756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Jellinger, “Pathology and pathogenesis of vascular cognitive impairment—a critical update,” Frontiers in Aging Neuroscience, vol. 5, article 17, Article ID Article 17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Camus, H. Kraehenbühl, M. Preisig, C. J. Büla, and G. Waeber, “Geriatric depression and vascular diseases: what are the links?” Journal of Affective Disorders, vol. 81, no. 1, pp. 1–16, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Tousoulis, N. Papageorgiou, E. Androulakis et al., “Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches,” Journal of the American College of Cardiology, vol. 62, no. 8, pp. 667–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Mogi and M. Horiuchi, “Neurovascular coupling in cognitive impairment associated with diabetes mellitus,” Circulation Journal, vol. 75, no. 5, pp. 1042–1048, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Serlin, J. Levy, and H. Shalev, “Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus,” Cardiovascular Psychiatry and Neurology, vol. 2011, Article ID 609202, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Umegaki, T. Hayashi, H. Nomura et al., “Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly,” Geriatrics & Gerontology International, vol. 13, no. 1, pp. 28–34, 2013. View at Publisher · View at Google Scholar · View at Scopus